Aquestive Therapeutics Inc (AQST) — Tangible Net Worth Ratio
Aquestive Therapeutics Inc (AQST) has a Tangible Net Worth Ratio of 98.0% as of December 2018. This metric is calculated by deducting intangible assets ($204.00K) from net assets ($10.08 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore AQST shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Aquestive Therapeutics Inc Tangible Net Worth Ratio (2005–2018)
This chart shows how Aquestive Therapeutics Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2005 to 2018. As of December 2018, the ratio stands at 98.0%, reflecting net assets of $10.08 Million with intangible assets of $204.00K USD. For live market cap and overall valuation, see Aquestive Therapeutics Inc (AQST) total market value.
Annual Tangible Net Worth Ratio for Aquestive Therapeutics Inc (2005–2018)
The table below presents the year-by-year Tangible Net Worth Ratio for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore AQST capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2018 | 98.0% | $10.08 Million | $204.00K | $86.85 Million | ▲ +4.6 pp |
| 2006 | 93.4% | $25.26 Million | $1.66 Million | $27.18 Million | ▲ +34.1 pp |
| 2005 | 59.3% | $4.67 Million | $1.90 Million | $12.31 Million | — |